CRISTALIA PRODUTOS QUIMICOS FARMACEUTICOS LTDA.;FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO - FAPESP
发明人:
申请号：
EP06775036.4
公开号：
EP1942934B1
申请日:
2006.09.12
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention relates to a product named "immunogenical complex", which comprises an adjuvant characterized by solid particles of highly ordinated nanostructured mesoporous silica, preferably, SBA-15 Silica, and vaccinal antigens of several natures, encapsulated in the referred to adjuvants. The immunogenical complex of the present invention allows the presentation of the antigens that compose it to lymphocytes, in a safe, gradual and extended way, which leads to a more efficient immunological memory, increases the immunogenicity of the antigen and improves the production of antibodies. This ensures an efficient immunological protection with fewer amounts of antigens and/or less repetitions of vaccinal doses. In addition, the characteristics of the immunogenical complex of the present invention promotes effective immunity induction, homogeneous in "god and bad respondent" individuals.
